Del Laboratories, Inc. to present at the Bear Stearns Fourteenth Annual Global Credit Conference

Del Laboratories, Inc. to present at the Bear Stearns Fourteenth
Annual Global Credit Conference 


UNIONDALE, N. Y., May 16  /PRNewswire-FirstCall/ -- Del Laboratories, Inc.
announced today that it will be presenting at the Bear Stearns Fourteenth
Annual Global Credit Conference on Wednesday, May 18, 2005, at 2:45PM (ET) at
the Waldorf-Astoria Hotel, New York City.  A call-in number has been set up.
Dial-in #:  800-683-1575. A digitized replay of the conference call will be
available from May 18, 2005 starting at 4:30 PM (ET) until June 15, 2005 at
11:59PM (ET).

Dial-in #:  877-519-4471--- Access Code:  6075627

Del Laboratories, Inc., markets and manufactures cosmetics and over the counter
pharmaceuticals. The Company's two flagship brands, Sally Hansen and Orajel,
are both leaders in their respective categories, and continue to build revenues
and market share.

Certain statements in this press release may constitute "forward-looking
statements" under the federal securities laws.  Forward-looking statements
contain information that is subject to certain risks, uncertainties, trends and
other factors that could cause actual results to be materially different from
any future results implied by such forward-looking statements.  Factors that
might cause such a difference include, but are not limited to: delays in
introducing new products or failure of consumers to accept new products;
actions by competitors which may result in mergers, technology improvement or
new product introductions; the dependence on certain national chain drug
stores, food stores and mass merchandiser relationships due to the
concentration of sales generated by such chains; changes in fashion-oriented
color cosmetic trends; the effect on sales of lower retailer inventory targets;
the effect on sales of political and/or economic conditions; the Company's
estimates of costs and benefits, cash flow from operations and capital
expenditures; interest rate or foreign exchange rate changes affecting the
Company and its market sensitive financial instruments including the Company's
qualitative and quantitative estimates as to market risk sensitive instruments;
changes in product mix to products which are less profitable; shipment delays;
depletion of inventory and increased production costs resulting from
disruptions of operations at any of our manufacturing or distribution
facilities; foreign currency fluctuations affecting our results of operations
and the value of our foreign assets and liabilities; the relative prices at
which we sell our products and our foreign competitors sell their products in
the same market; our operating and manufacturing costs outside of the United
States; changes in the laws, regulations and policies, including changes in
accounting standards, that effect, or will effect, us in the United States
and/or abroad; and trends in the general economy.  Although the Company
believes that the expectations reflected in such forward-looking statements are
based upon reasonable assumptions, it can give no assurance that its
expectations will be achieved.  Without limitation, use of the following words
is intended to identify forward-looking statements: "may," "will," "should,"
"expect," "anticipate," "estimate," "intend," "plan," or "continue" or the
negative thereof or other variations thereon.  For further information on
factors which could impact the Company and the statements contained herein,
please refer to the Company's filings with the Securities and Exchange
Commission, including without limitation the Company's Annual Report on Form
10-K and the "Management's Discussion and Analysis of Financial Condition and
Results of Operations" contained or incorporated by reference therein and
quarterly reports on Form 10-Q.

Filings with the Securities and Exchange Commission are available on the
Company's website at http://www.dellabs.com/. 

DATASOURCE: Del Laboratories, Inc.



CONTACT:  Enzo J. Vialardi, Executive Vice President and Chief Financial

Officer, Del Laboratories, Inc., [phone]



Web site:  http://www.dellabs.com/ 

Copyright